Aortic Insufficiency

7

Review clinical trials related to Aortic Insufficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)

Participants needed: 1,016
Trial details
Biological sex: AllType: InterventionalSponsor: JenaValve Technology, Inc.Updated: Jun 25, 2026Locations: 28
Eligibility criteria

Class I or II indication for AVR according to ACC/AHA or ESC/EACTS guidelines wi... [+4]

Confirmed moderate (2+) or less AR severity by core laboratory evaluation [+51]

Status: Recruiting

The JenaValve ALIGN-AR LVAD Registry

To evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated for TAVR

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: JenaValve Technology, Inc.Updated: Apr 1, 2026Locations: 15
Eligibility criteria

Patient with NYHA functional class III/IV [+4]

Congenital uni- or bicuspid (Sievers 0) aortic valve morphology [+20]

Status: Not yet recruiting

Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve

Evaluation of clinical outcomes and valve performance of the SAPIEN 3 Ultra Resilia (S3UR) valve over 10 years.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institut für Pharmakologie und Präventive MedizinUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Adult patients (≥18 years) [+2]

Lack of written informed consent [+13]

Status: Recruiting

ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy

The overall purpose of ART trial is to establish the Safety and Efficacy of the J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients with Grade≥3+ Native Aortic Regurgitation.

Participants needed: 1,250
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Mar 10, 2026Locations: 12
Eligibility criteria

1) Age ≥65 years; [+8]

1. Confirmed moderate or less AR severity (Grade≤2+) by core laboratory evaluati... [+54]

Status: Not yet recruiting

JOURNEY LVAD: JOURNEY Left Ventricular Assist Device

The objective of this study is to assess the safety and effectiveness of the J-Valve Transfemoral Transcatheter Heart Valve System in patients on left ventricular assist device (LVAD) support with significant native aortic valve regurgitation (AR).

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: JC Medical, Inc., an affiliate of Edwards Lifesciences LLCUpdated: Mar 5, 2026
Eligibility criteria

Adult with durable left ventricular assist device (LVAD) support and clinically... [+4]

Prior aortic valve replacement or repair [+33]

Status: Recruiting

Impact of Anesthesia, Positive Pressure Ventilation and Modality of Imaging on the Echocardiographic Assessment of the Severity of Aortic Regurgitation

The goal of this observational study is to assess the impact of imaging modality (trans-thoracic echo (TTE) vs trans-esophageal echo (TEE)), anesthesia and positive pressure ventilation on the grading of aortic insufficiency. Patients scheduled for cardiac surgery and in whom a TEE is going to be performed intra-operatively will be enrolled. The grading of the aortic insufficiency will be compared between a TTE performed immediately before the induction of general anesthesia end the TEE performed after induction of general anesthesia.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of LiegeUpdated: Apr 10, 2025Locations: 1
Eligibility criteria

Known aortic regurgitation of any grade [+1]

Non sinus rhythm [+4]

Status: Recruiting

Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients

The goal of this interventional is to assess advantages of the ultrasound examination of the lungs in the early postoperative period in cardiac surgical patients after heart surgeries requiring cardiopulmonary bypass. Evaluation of pulmonary complications and outcomes during mid-term follow-up, as well as comparison of ultrasound examination and traditional roentgenologic methods (X-ray examination and CT of the chest) will be performed. The main question\[s\] it aims to answer are: * Is ultrasound examination of the lungs a more specific and sensitive method in identification of early postoperative pulmonary complications after on-pump cardiac surgical procedures, in comparison with traditional X-ray methods. * Does early identification of interstitial pulmonary edema (based on number of visualised B-lines in the early postoperative period), influences mid-term outcomes in this cohort of patients Participants will undergo ultrasound examination of the lungs on postoperative day 1, 3, 5 and 7 after heart surgery. Based on ultrasound findings and degree of interstitial pulmonary edema, medical (diuretics, anti-inflammatory, e.t.c) therapy will be modified. Researchers will compare this group of patients with control group, in which ultrasound examination will be performed in the same time frames, but no changes in medical management based on ultrasound findings will be made to see if timely administered medical therapy, based on ultrasound findings, can significantly improve symptoms, hospital lengths of stay and outcomes of this patients.

Participants needed: 186
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Saint Petersburg State University, RussiaUpdated: Dec 9, 2024Locations: 1
Eligibility criteria

open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 an... [+1]

reoperations on the open heart with CPB [+4]